First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
Recruiting · NCT06622486 · Registry updated 2024-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2024-11-07 | NCT06622486 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Egle Therapeutics | 1 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centr Georges Francois Leclerc | Dijon | France | 1 |
| Clinica Universidad De Navarra | Pamplona | Spain | 20 |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | 21 |
| Hospital Universitari Vall D Hebron | Barcelona | Spain | 7 |
| Hospital Universitario Fundacion Jimenez Diaz | Madrid | Spain | 16 |
| Institut Curie | Paris | France | 44 |
| Institut Gustave Roussy | Paris | France | 9 |
| Institut Regional Du Cancer de Montpellier | Montpellier | France | 4 |